4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004773
CEO and Chairman sold 8,400 shares at an average $70.43 ($591,600)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2021-01-19 | Sale | −8,300 | $70.42 | $584,486 | 1,769,880 | D: show line 1 in the form |
| ROBINS CHAD M CEO and Chairman | 2021-01-19 | Sale | −100 | $71.14 | $7,114 | 1,769,780 | D: show line 2 in the form |
| Open-market sales · 8,400 sh · avg $70.43 · $591,600 | |||||||
Loading xslF345X03/doc4.xml…